Related Experiment Videos

Response to the article "Sorafenib as a potential strategy for refractory pulmonary arterial hypertension"

Jason Weatherald1, Marc Humbert2, Christophe Guignabert3

  • 1Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France; Service de Pneumologie, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France; University of Calgary, Department of Medicine, Division of Respirology, Calgary, Alberta, Canada.

Pulmonary Pharmacology & Therapeutics
|April 9, 2017
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos